The vaccine for Coronavirus: When can we have it?

Every day there are new data from scientific labs working on the vaccine against Corona virus, and while the first tests for volunteers have begun in China and the US, Germans, Russians, Israelis, Canadians are also seeking a solution.

The incentive is certainly statistics in the number of patients so far, more than 4,16700 cases have been confirmed worldwide, and more than 18,500 thousand people have died.

The world is joining a so-called “prejudice solidarity” for possible corona virus therapy, initiated by O BSH and so far, with 10 participating countries confirming the testing of four already existing drugs. Among them is “Remdesivivir”, an experimental drug developed during the Ebola epidemic that holds today's expectations of the world.

The first treatment for Remdesivirier has been used by Italian sides, as a patient affected by COVID-19 had a negative result in virus corona.

At the same time, Chinese officials claim the Japanese drug “Favipiraver”, also known as “Avian”, has proved effective in defeating the virus. This flu - related drug is produced by Tojama Chemiscal, a branch of Fujifilm, which is already known in pharmacology except for cameras.

However, health and pharmaceutical experts are currently skeptical about bringing any of these drugs when they are widely used.

“We need to make sure that the vaccine is absolutely safe. It'll take at least a year. We will find a vaccine, but we must do what is necessary”, World Health Organisation Executive Director (WHO) said. Mike Ryan.

Antimalarial bars have been mentioned during the long days, also as possible solutions.

When will drugs be used extensively?

All these drugs have actually been developed to treat other diseases, and thus far 39 projects are being developed to work on the vaccine of the virus. Although there are no concrete solutions, clinical test on volunteers has already begun in China and the United States. While the Russians are testing prototypes of possible animal vaccines. In any case, the vaccine will require a minimum of 12 to 18 months.

This was confirmed by SiegfriedTrom by the National Research Company Alliance in Germany, which also says many companies and scientific organisations worldwide are seeking to develop a vaccine against the virus.

The more companies are involved, the more likely they are to produce the vaccine as soon as”, he says.
The Canadian Bio-Farmaceutic Company Medica Go was among the first to offer a solution to the treatment of the virus. Thirty percent of its shares are owned by Philip Morris, who, unlike what is expected by tobacco companies, has invested intensively in the development of science and technology.

This biotechnology company soon came up with a solution because it used a tobacco plant instead of chicken eggs as a plant for vaccines, which are used mainly in traditional drug distribution.

The Medicago project is also mid-applicants at the Strategic Innovation Fund COVID-19 in Canada, which will split $192m into research funds.

German pharmaceutical company CureVac, followed by Ditmar Hop, the German billionaire and owner of the Hofenheim football club, is hosting her vaccine in the fall.

Vaccines Worldwide

Experts say that due to pandemic and competition between pharmaceutical companies gone, the development of vaccines will not last for many years, as is usually the case. And they point out that the medicine should not be available only to privileged individuals or states. That's why speculation has been created about the possible purchase of vaccine by the American President Trump. But CureVac's leaders claimed that if they were successful in developing the vaccine, it would be available to the whole world.